Cargando…

The role of 3-ketosteroid 1(2)-dehydrogenase in the pathogenicity of Mycobacterium tuberculosis

BACKGROUND: A growing body of evidence suggests that Mycobacterium tuberculosis (Mtb) uses the host’s cholesterol as a source of carbon and energy during infection. Strains defective in cholesterol transport or degradation exhibit attenuated growth in activated macrophages and diminished infectivity...

Descripción completa

Detalles Bibliográficos
Autores principales: Brzezinska, Marta, Szulc, Izabela, Brzostek, Anna, Klink, Magdalena, Kielbik, Michal, Sulowska, Zofia, Pawelczyk, Jakub, Dziadek, Jaroslaw
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599626/
https://www.ncbi.nlm.nih.gov/pubmed/23425360
http://dx.doi.org/10.1186/1471-2180-13-43
_version_ 1782263006216847360
author Brzezinska, Marta
Szulc, Izabela
Brzostek, Anna
Klink, Magdalena
Kielbik, Michal
Sulowska, Zofia
Pawelczyk, Jakub
Dziadek, Jaroslaw
author_facet Brzezinska, Marta
Szulc, Izabela
Brzostek, Anna
Klink, Magdalena
Kielbik, Michal
Sulowska, Zofia
Pawelczyk, Jakub
Dziadek, Jaroslaw
author_sort Brzezinska, Marta
collection PubMed
description BACKGROUND: A growing body of evidence suggests that Mycobacterium tuberculosis (Mtb) uses the host’s cholesterol as a source of carbon and energy during infection. Strains defective in cholesterol transport or degradation exhibit attenuated growth in activated macrophages and diminished infectivity in animal models. The aim of this study was to evaluate intracellular replication of a cholesterol degradation-deficient Mtb mutant in human macrophages (MØ) in vitro and assess the functional responses of Mtb mutant-infected MØ. RESULTS: A mutant Mtb H37Rv strain containing an inactivated kstD gene (∆kstD), which encodes 3-ketosteroid 1(2)-dehydrogenase (KstD), was previously prepared using the homologous recombination-based gene-replacement technique. A control strain carrying the kstD gene complemented with an intact kstD was also previously constructed. In this study, human resting MØ were obtained after overnight differentiation of the human monocyte-macrophage cell line THP-1. Resting MØ were further activated with interferon-γ (IFN-γ). The ability of the kstD-defective Mtb mutant strain to replicate intracellularly in human MØ was evaluated using a colony-forming assay. Nitric oxide (NO) and reactive oxygen species (ROS) production by MØ infected with wild-type or ∆kstD strains was detected using Griess reagent and chemiluminescence methods, respectively. The production of tumor necrosis factor-α and interleukin-10 by MØ after infection with wild-type or mutant Mtb was examined using enzyme-linked immunosorbent assays. We found that replication of mutant Mtb was attenuated in resting MØ compared to the wild-type or complemented strains. Moreover, the mutant was unable to inhibit the NO and ROS production induced through Toll-like receptor 2 (TLR2) signaling in infected resting MØ. In contrast, mutant and wild-type Mtb behaved similarly in MØ activated with IFN-γ before and during infection. CONCLUSIONS: The Mtb mutant ∆kstD strain, which is unable to use cholesterol as a source of carbon and energy, has a limited ability to multiply in resting MØ following infection, reflecting a failure of the ∆kstD strain to inhibit the TLR2-dependent bactericidal activity of resting MØ.
format Online
Article
Text
id pubmed-3599626
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35996262013-03-17 The role of 3-ketosteroid 1(2)-dehydrogenase in the pathogenicity of Mycobacterium tuberculosis Brzezinska, Marta Szulc, Izabela Brzostek, Anna Klink, Magdalena Kielbik, Michal Sulowska, Zofia Pawelczyk, Jakub Dziadek, Jaroslaw BMC Microbiol Research Article BACKGROUND: A growing body of evidence suggests that Mycobacterium tuberculosis (Mtb) uses the host’s cholesterol as a source of carbon and energy during infection. Strains defective in cholesterol transport or degradation exhibit attenuated growth in activated macrophages and diminished infectivity in animal models. The aim of this study was to evaluate intracellular replication of a cholesterol degradation-deficient Mtb mutant in human macrophages (MØ) in vitro and assess the functional responses of Mtb mutant-infected MØ. RESULTS: A mutant Mtb H37Rv strain containing an inactivated kstD gene (∆kstD), which encodes 3-ketosteroid 1(2)-dehydrogenase (KstD), was previously prepared using the homologous recombination-based gene-replacement technique. A control strain carrying the kstD gene complemented with an intact kstD was also previously constructed. In this study, human resting MØ were obtained after overnight differentiation of the human monocyte-macrophage cell line THP-1. Resting MØ were further activated with interferon-γ (IFN-γ). The ability of the kstD-defective Mtb mutant strain to replicate intracellularly in human MØ was evaluated using a colony-forming assay. Nitric oxide (NO) and reactive oxygen species (ROS) production by MØ infected with wild-type or ∆kstD strains was detected using Griess reagent and chemiluminescence methods, respectively. The production of tumor necrosis factor-α and interleukin-10 by MØ after infection with wild-type or mutant Mtb was examined using enzyme-linked immunosorbent assays. We found that replication of mutant Mtb was attenuated in resting MØ compared to the wild-type or complemented strains. Moreover, the mutant was unable to inhibit the NO and ROS production induced through Toll-like receptor 2 (TLR2) signaling in infected resting MØ. In contrast, mutant and wild-type Mtb behaved similarly in MØ activated with IFN-γ before and during infection. CONCLUSIONS: The Mtb mutant ∆kstD strain, which is unable to use cholesterol as a source of carbon and energy, has a limited ability to multiply in resting MØ following infection, reflecting a failure of the ∆kstD strain to inhibit the TLR2-dependent bactericidal activity of resting MØ. BioMed Central 2013-02-20 /pmc/articles/PMC3599626/ /pubmed/23425360 http://dx.doi.org/10.1186/1471-2180-13-43 Text en Copyright ©2013 Brzezinska et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Brzezinska, Marta
Szulc, Izabela
Brzostek, Anna
Klink, Magdalena
Kielbik, Michal
Sulowska, Zofia
Pawelczyk, Jakub
Dziadek, Jaroslaw
The role of 3-ketosteroid 1(2)-dehydrogenase in the pathogenicity of Mycobacterium tuberculosis
title The role of 3-ketosteroid 1(2)-dehydrogenase in the pathogenicity of Mycobacterium tuberculosis
title_full The role of 3-ketosteroid 1(2)-dehydrogenase in the pathogenicity of Mycobacterium tuberculosis
title_fullStr The role of 3-ketosteroid 1(2)-dehydrogenase in the pathogenicity of Mycobacterium tuberculosis
title_full_unstemmed The role of 3-ketosteroid 1(2)-dehydrogenase in the pathogenicity of Mycobacterium tuberculosis
title_short The role of 3-ketosteroid 1(2)-dehydrogenase in the pathogenicity of Mycobacterium tuberculosis
title_sort role of 3-ketosteroid 1(2)-dehydrogenase in the pathogenicity of mycobacterium tuberculosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599626/
https://www.ncbi.nlm.nih.gov/pubmed/23425360
http://dx.doi.org/10.1186/1471-2180-13-43
work_keys_str_mv AT brzezinskamarta theroleof3ketosteroid12dehydrogenaseinthepathogenicityofmycobacteriumtuberculosis
AT szulcizabela theroleof3ketosteroid12dehydrogenaseinthepathogenicityofmycobacteriumtuberculosis
AT brzostekanna theroleof3ketosteroid12dehydrogenaseinthepathogenicityofmycobacteriumtuberculosis
AT klinkmagdalena theroleof3ketosteroid12dehydrogenaseinthepathogenicityofmycobacteriumtuberculosis
AT kielbikmichal theroleof3ketosteroid12dehydrogenaseinthepathogenicityofmycobacteriumtuberculosis
AT sulowskazofia theroleof3ketosteroid12dehydrogenaseinthepathogenicityofmycobacteriumtuberculosis
AT pawelczykjakub theroleof3ketosteroid12dehydrogenaseinthepathogenicityofmycobacteriumtuberculosis
AT dziadekjaroslaw theroleof3ketosteroid12dehydrogenaseinthepathogenicityofmycobacteriumtuberculosis
AT brzezinskamarta roleof3ketosteroid12dehydrogenaseinthepathogenicityofmycobacteriumtuberculosis
AT szulcizabela roleof3ketosteroid12dehydrogenaseinthepathogenicityofmycobacteriumtuberculosis
AT brzostekanna roleof3ketosteroid12dehydrogenaseinthepathogenicityofmycobacteriumtuberculosis
AT klinkmagdalena roleof3ketosteroid12dehydrogenaseinthepathogenicityofmycobacteriumtuberculosis
AT kielbikmichal roleof3ketosteroid12dehydrogenaseinthepathogenicityofmycobacteriumtuberculosis
AT sulowskazofia roleof3ketosteroid12dehydrogenaseinthepathogenicityofmycobacteriumtuberculosis
AT pawelczykjakub roleof3ketosteroid12dehydrogenaseinthepathogenicityofmycobacteriumtuberculosis
AT dziadekjaroslaw roleof3ketosteroid12dehydrogenaseinthepathogenicityofmycobacteriumtuberculosis